Log in to save to my catalogue

Genuine Selective Caspase-2 Inhibition with new Irreversible Small Peptidomimetics

Genuine Selective Caspase-2 Inhibition with new Irreversible Small Peptidomimetics

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2610243930

Genuine Selective Caspase-2 Inhibition with new Irreversible Small Peptidomimetics

About this item

Full title

Genuine Selective Caspase-2 Inhibition with new Irreversible Small Peptidomimetics

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2021-12

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Caspase-2 (Casp2) is a promising therapeutic target in several human diseases including nonalcoholic steatohepatitis (NASH) and Alzheimer's disease (AD). However, the design of active-site-directed inhibitor selective to individual caspase family members is challenging because caspases have extremely similar active sites. Here we present new peptid...

Alternative Titles

Full title

Genuine Selective Caspase-2 Inhibition with new Irreversible Small Peptidomimetics

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2610243930

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2610243930

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2021.12.13.472505